Drugs / colloidal bismuth pectin

Trials 8

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 46 trials · 1 met primary
Phase 4 NCT05049902 Sep 2021 → May 2023 Helicobacter pylori infectious disease Shandong University Completed Met primary
Phase 4 NCT04901117 Jun 2021 → Jun 2023 Helicobacter pylori infectious disease Shandong University Unknown No outcome recorded
Phase 4 NCT03616405 Apr → Nov 2019 Helicobacter pylori infectious disease Shandong University Unknown No outcome recorded
Phase 4 NCT03565484 Jan 2019 → May 2020 Helicobacter pylori infectious disease Shandong University Unknown No outcome recorded
Phase 4 NCT03571230 Jul 2018 → Dec 2019 Helicobacter pylori infectious disease Shandong University Unknown No outcome recorded
Phase 4 NCT02933229 Oct 2016 → Oct 2031 expected Helicobacter pylori infectious disease, gastric intestinal metaplasia Shandong University Not yet recruiting No outcome recorded
Phase not applicable2 trials · 1 missed
— NCT05549115 Sep 2022 → Feb 2024 Helicobacter pylori infectious disease Liaocheng People's Hospital Unknown Missed primary
— NCT04923113 Jun 2021 → Jan 2022 Helicobacter pylori infectious disease Second Affiliated Hospital, School of Medicine, Zhejiang University Completed No outcome recorded
Comparator or background therapy13 trials
Phase 0 NCT06777732 Background Mar → Sep 2025 overdue Helicobacter pylori infectious disease Nanjing First Hospital, Nanjing Medical University Not yet recruiting No outcome recorded
Phase 1/2 NCT06823791 Background Aug 2022 → Jul 2024 Helicobacter pylori infectious disease Liaocheng People's Hospital Completed No outcome recorded
Phase 4 NCT05647278 Comparator Nov 2023 → Sep 2025 Helicobacter pylori infectious disease Zhang Xiaofeng,MD Completed No outcome recorded
Phase 4 NCT06168214 Comparator Sep 2023 → Nov 2024 overdue — Xijing Hospital of Digestive Diseases Recruiting No outcome recorded
Phase 4 NCT05419674 Comparator Aug 2022 → Aug 2023 Helicobacter pylori infectious disease Second Affiliated Hospital, School of Medicine, Zhejiang University Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 21 sources stand behind the page.

FieldValueCited text
Known as Colloidal Bismuth Pectin “esomeprazole (20 mg, twice daily), colloidal bismuth pectin (150 mg, four times daily), clarithromycin (500 mg, twice daily), and amoxicillin (1.0 g, twice daily) for 14 days” NCT05549115 ↗
20

“esomeprazole magnesium 20 mg bid +colloidal bismuth pectin 200mg bid + amoxicillin 1000 mg bid + furazolidone 100 mg bid, for 14 days.” NCT06823791 ↗

“Conventional Quadruple Therapy: Vonoprazan 20mg BID; Colloidal Bismuth Pectin 220mg BID; Amoxicillin 1.0g BID; tetracycline 0.5g TID.” NCT07533422 ↗

“The regimen contains rabeprazole 20mg bid, colloidal bismuth pectin 200mg bid, and two sensitive antibiotics determined by AST.” NCT03565484 ↗

“H. pylori eradication therapy comprising esomeprazole, amoxicillin,clarithromycin and colloidal bismuth pectin.” NCT02933229 ↗

“Colloidal Bismuth Pectin 200mg bid po” NCT04723472 ↗

“colloidal bismuth pectin 300mg bid” NCT06168214 ↗

NCT03571230 ↗

NCT05049902 ↗

NCT04907747 ↗

NCT05647278 ↗

Show 10 more sources

Route Oral “Colloidal Bismuth Pectin 200mg bid po” NCT04723472 ↗